Results for Biotechnology:
Sloan Distinguished Associate Professor of Technological Innovation, Entrepreneurship, and Strategic Management
Contact: (617) 258-9766, pazoulay@mit.edu
Expertise: Alliances; Biopharmaceutical; Biotechnology; Clinical trials; Compensation; Competitive strategy; Corporate strategy and policy; Econometrics; Economics of organizations; Employee motivation; Employment relations; Human resource management; Incentives, corporate; Incentives, customer; Industrial economics; Innovation; Intellectual property; Intellectual property law; Labor market policy; Management of technology; Non-market strategy; Patents; Pharmaceutical; Research and development; Social networks; Strategic management; Technological innovation; Technology strategy; Technology transfer
Department: Lecturer, Global Economics and Management
Contact: (617) 953-4558, bozkaya@mit.edu
Expertise: Angel investing; Banking regulation; Biotechnology; Business plans; Cross-cultural awareness; Cultural differences; Developing countries, economics; Emerging businesses; Emerging markets; Energy; Entrepreneurial finance; Entrepreneurial management; Entrepreneurship / New ventures; Equities; Global entrepreneurship; Innovation; Investment banking; Investment risk; Labor market policy; Management of technology; Middle East; Non-profits; Paper industry; Private equity; Startups; Strategic management; Technological innovation; Venture capital
Chrysler Leaders for Global Operations Professor of Management
Department: Professor of Operations Management and Engineering Systems
Contact: (617) 253-3632, charley@mit.edu
Expertise: Offshoring; Outsourcing; Supply chain management
Department: Senior Lecturer, Trust Center for MIT Entrepreneurship
Contact: (617) 357-7474, jfleming@oxbio.com
Expertise: $100K Entrepreneurship Competition; Alliances; Analysts forecasts; Angel investing; Applied economics; Biopharmaceutical; Biotechnology; Business plans; Cancer, multi-drug therapy models; Capital budgeting; Capital market; CEO compensation; Corporate diversification; Corporate finance; Corporate governance; Economic history; Economics; Economics of organizations; Emerging businesses; Entrepreneurial finance; Entrepreneurship / New ventures; Euro; Federal Reserve; Finance; Financial engineering; Financial reporting; Foreign investment; Genetics; Germany; Health management; Healthcare industry; Hedge funds; HIV, multi-drug therapy models; Industrial economics; Investment analysis; Knowledge management; Medical devices; Medicine; Mergers and acquisitions; Microeconomics; Middle East; New ventures; Patents; Political economy; Research and development; Sarbanes-Oxley compliance; Startups; Technological innovation; Venture capital
David Sarnoff Professor of Management of Technology
Department: Associate Professor of Technological Innovation, Entrepreneurship, and Strategic Management
Contact: (617) 253-3681, fmurray@mit.edu
Expertise: $100K Entrepreneurship competition; Biopharmaceutical; Biotechnology; China; Clinical trials; Drug models; Emerging businesses; Energy; Entrepreneurial management; Entrepreneurship / New ventures; Gender issues; Genetics; Healthcare operations management; Human resource management; India; Innovation; Institutional partnerships; Intellectual property; Intellectual property law; Knowledge management; Law; Lead users; Management of engineers and scientists; Management of technology; Medical decision making; New ventures; Patents; Pharmaceutical; Research and development; Social networks; Startups; Technological innovation
Department: Lecturer, Martin Trust Center for MIT Entrepreneurship
Contact: (781) 684-0239, azarur@mit.edu
Expertise: Biopharmaceutical; Biotechnology; Business plans; Climate policy; Clinical trials; Drug and biological regulatory strategies; Drug models; Emerging businesses; Energy; Entrepreneurial management; Entrepreneurship / New ventures; Environment; Global climate change; Global warming; Healthcare; Innovation; Medical devices; Mexico; New ventures; Pharmaceutical; Research and development; Startup; Venture capital
After 205 years, DuPont has transformed itself substantially while remaining true to its character, suggests Ellen Kullman. "We're a company with a passion for science," says Kullman. DuPont, which got its start making black powder for explosives, pursued chemicals for its first 100 years, but is now taking its science into energy, biotechnology and nanotechnology, with products and services in agriculture, nutrition, coating and color technologies, performance materials and safety and protection.
Contact us.
Paul Denning
Director of Media
Relations
617.253.0576
denning@mit.edu
Patricia Favreau
Associate Director of
Media Relations
617.253.3492
pfavreau@mit.edu
